The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Scangos George A | Director | Grant(A) | 30K | — | $0 |
| Jun 9, 2026 | Mackey Catherine J | Director | Grant(A) | 30K | — | $0 |
| Feb 24, 2026 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 4K | $3.76 | $16K |
| Feb 24, 2026 | Jorgensen Nathan D. | Chief Financial Officer | Sell(S) | 5K | $3.77 | $18K |
| Feb 24, 2026 | Sandrock Alfred | President and CEO, Director | Sell(S) | 14K | $3.79 | $54K |
| Feb 24, 2026 | Swartz Robin | COO & CBO | Sell(S) | 6K | $3.77 | $24K |
| Feb 18, 2026 | Sandrock Alfred | President and CEO, Director | Sell(S) | 12K | $3.41 | $40K |
| Feb 18, 2026 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 3K | $3.44 | $11K |
| Feb 18, 2026 | Swartz Robin | COO & CBO | Sell(S) | 4K | $3.44 | $13K |
| Feb 10, 2026 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 4K | $3.85 | $14K |
| Feb 10, 2026 | Sandrock Alfred | President and CEO, Director | Sell(S) | 12K | $3.78 | $46K |
| Feb 10, 2026 | Swartz Robin | COO & CBO | Sell(S) | 5K | $3.85 | $18K |
| Feb 6, 2026 | Jorgensen Nathan D. | Chief Financial Officer | Grant(A) | 32K | — | $0 |
| Feb 6, 2026 | Jorgensen Nathan D. | Chief Financial Officer | Grant(A) | 151K | — | $0 |
| Feb 6, 2026 | Sandrock Alfred | President and CEO, Director | Grant(A) | 86K | — | $0 |
| Feb 6, 2026 | Sandrock Alfred | President and CEO, Director | Grant(A) | 403K | — | $0 |
| Feb 6, 2026 | Swartz Robin | COO & CBO | Grant(A) | 45K | — | $0 |
| Feb 6, 2026 | Swartz Robin | COO & CBO | Grant(A) | 210K | — | $0 |
| Feb 6, 2026 | Carter Todd Alfred | Chief Scientific Officer | Grant(A) | 33K | — | $0 |
| Feb 6, 2026 | Carter Todd Alfred | Chief Scientific Officer | Grant(A) | 154K | — | $0 |
| Feb 6, 2026 | Ferguson Toby | Chief Medical Officer | Grant(A) | 45K | — | $0 |
| Feb 6, 2026 | Ferguson Toby | Chief Medical Officer | Grant(A) | 210K | — | $0 |
| Jan 6, 2026 | Shiferman Gregory L. | SVP and General Counsel | Grant(A) | 100K | — | $0 |
| Oct 3, 2025 | Jorgensen Nathan D. | Chief Financial Officer | Sell(S) | 8K | $4.78 | $37K |
| Aug 18, 2025 | Ferguson Toby | Chief Medical Officer | Sell(S) | 19K | $3.73 | $71K |
| Jun 3, 2025 | Colon Grace | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Geraghty James A | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Higgins Michael J | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Hyman Steven | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Mackey Catherine J | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Onyia Jude | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Pierce Glenn | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Scangos George A | Director | Grant(A) | 24K | — | $0 |
| Jun 3, 2025 | Vitale Nancy | Director | Grant(A) | 24K | — | $0 |
| Apr 2, 2025 | Sandrock Alfred | President and CEO, Director | Sell(S) | 11K | $3.43 | $37K |
| Apr 2, 2025 | Ferguson Toby | Chief Medical Officer | Sell(S) | 10K | $3.43 | $35K |
| Feb 21, 2025 | Jorgensen Nathan D. | Chief Financial Officer | Grant(A) | 52K | — | $0 |
| Feb 21, 2025 | Jorgensen Nathan D. | Chief Financial Officer | Grant(A) | 103K | — | $0 |
| Feb 21, 2025 | Ferguson Toby | Chief Medical Officer | Grant(A) | 63K | — | $0 |
| Feb 21, 2025 | Ferguson Toby | Chief Medical Officer | Grant(A) | 126K | — | $0 |
| Feb 21, 2025 | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant(A) | 42K | — | $0 |
| Feb 21, 2025 | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant(A) | 83K | — | $0 |
| Feb 21, 2025 | Swartz Robin | COO & CBO | Grant(A) | 71K | — | $0 |
| Feb 21, 2025 | Swartz Robin | COO & CBO | Grant(A) | 143K | — | $0 |
| Feb 21, 2025 | Sandrock Alfred | President and CEO, Director | Grant(A) | 145K | — | $0 |
| Feb 21, 2025 | Sandrock Alfred | President and CEO, Director | Grant(A) | 290K | — | $0 |
| Feb 21, 2025 | Carter Todd Alfred | Chief Scientific Officer | Grant(A) | 46K | — | $0 |
| Feb 21, 2025 | Carter Todd Alfred | Chief Scientific Officer | Grant(A) | 92K | — | $0 |
| Feb 20, 2025 | Swartz Robin | COO & CBO | Sell(S) | 4K | $4.25 | $17K |
| Feb 20, 2025 | Sandrock Alfred | President and CEO, Director | Sell(S) | 12K | $4.24 | $50K |
| Feb 20, 2025 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 3K | $4.26 | $14K |
| Feb 11, 2025 | Fahey Sandell Jacquelyn | Chief Legal Officer | Sell(S) | 4K | $4.45 | $19K |
| Feb 11, 2025 | Sandrock Alfred | President & CEO | Sell(S) | 17K | $4.45 | $74K |
| Feb 11, 2025 | Swartz Robin | COO & CBO | Sell(S) | 7K | $4.45 | $31K |
| Feb 11, 2025 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 5K | $4.45 | $24K |
| Jan 14, 2025 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 1K | $5.13 | $6K |
| Jan 14, 2025 | Swartz Robin | COO & CBO | Sell(S) | 3K | $5.09 | $16K |
| Dec 23, 2024 | Swartz Robin | COO&CBO | Sell(S) | 7K | $5.65 | $37K |
| Oct 2, 2024 | Fahey Sandell Jacquelyn | Chief Legal Officer | Sell(S) | 6K | $5.82 | $35K |
| Oct 1, 2024 | Jorgensen Nathan D. | Chief Financial Officer | Grant(A) | 80K | — | $0 |
| Jul 8, 2024 | Jorgensen Nathan D. | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Jun 5, 2024 | Colon Grace | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Geraghty James A | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Higgins Michael J | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Hyman Steven | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Mackey Catherine J | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Onyia Jude | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Pierce Glenn | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Scangos George A | Director | Grant(A) | 24K | — | $0 |
| Jun 5, 2024 | Vitale Nancy | Director | Grant(A) | 24K | — | $0 |
| Apr 2, 2024 | Sandrock Alfred | President and CEO, Director | Sell(S) | 12K | $9.86 | $119K |
| Apr 2, 2024 | Swartz Robin | Chief Operating Officer | Sell(S) | 1K | $9.88 | $13K |
| Apr 1, 2024 | Ferguson Toby | Chief Medical Officer | Grant(A) | 105K | — | $0 |
| Mar 25, 2024 | Ferguson Toby | Chief Medical Officer | Grant(A) | 210K | — | $0 |
| Feb 21, 2024 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 3K | $7.47 | $25K |
| Feb 21, 2024 | Pfreundschuh Peter P. | Chief Financial Officer | Sell(S) | 4K | $7.46 | $28K |
| Feb 21, 2024 | Sandrock Alfred | President and CEO, Director | Sell(S) | 13K | $7.46 | $97K |
| Feb 21, 2024 | Swartz Robin | Chief Operating Officer | Sell(S) | 4K | $7.45 | $30K |
| Feb 20, 2024 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 602 | $7.68 | $5K |
| Feb 9, 2024 | Pfreundschuh Peter P. | Chief Financial Officer | Grant(A) | 30K | — | $0 |
| Feb 9, 2024 | Pfreundschuh Peter P. | Chief Financial Officer | Grant(A) | 60K | — | $0 |
| Feb 9, 2024 | Sandrock Alfred | President and CEO, Director | Grant(A) | 130K | — | $0 |
| Feb 9, 2024 | Sandrock Alfred | President and CEO, Director | Grant(A) | 260K | — | $0 |
| Feb 9, 2024 | Swartz Robin | Chief Operating Officer | Grant(A) | 50K | — | $0 |
| Feb 9, 2024 | Swartz Robin | Chief Operating Officer | Grant(A) | 100K | — | $0 |
| Feb 9, 2024 | Carter Todd Alfred | Chief Scientific Officer | Grant(A) | 39K | — | $0 |
| Feb 9, 2024 | Carter Todd Alfred | Chief Scientific Officer | Grant(A) | 77K | — | $0 |
| Feb 9, 2024 | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant(A) | 31K | — | $0 |
| Feb 9, 2024 | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant(A) | 62K | — | $0 |
| Jan 17, 2024 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 1K | $7.18 | $9K |
| Jan 17, 2024 | Swartz Robin | Chief Operating Officer | Sell(S) | 3K | $7.15 | $18K |
| Oct 3, 2023 | Pfreundschuh Peter P. | Chief Financial Officer | Sell(S) | 14K | $6.99 | $95K |
| Oct 1, 2023 | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant(A) | 61K | — | $0 |
| Sep 15, 2023 | Carter Todd Alfred | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Sep 15, 2023 | Carter Todd Alfred | Chief Scientific Officer | Option exercise(M) | 5K | $2.85 | $14K |
| Sep 15, 2023 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 11K | $8.16 | $86K |
| Jul 10, 2023 | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant(A) | 122K | — | $0 |
| Jul 6, 2023 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 6K | $10.80 | $59K |
| Jun 30, 2023 | Carter Todd Alfred | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Jun 30, 2023 | Carter Todd Alfred | Chief Scientific Officer | Sell(S) | 5K | $11.41 | $57K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).